Carboplatin + NAB-PACLITAXEL + Cetuximab + CISPLATIN for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Oct 2014: Trial registered, NCT02270814
  2. 2 Feb 2015: Trial started, NCT02270814

The trials

NCT02270814: Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma

State
Under way
Phase
Phase 2
People
74 taking part
Started
2 Feb 2015
Primary completion
30 Sep 2026
Arms
CACTUX: nab-paclitaxel, cisplatin (or carboplatin), cetuximab
Results
None posted
  1. 21 Oct 2014: Trial registered
  2. 2 Feb 2015: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.